報價延遲最少15分鐘:2025/01/21 18:39 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
108.71 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-4.85/-0.70
|
|
企業價值
3.51B
|
| 資產負債 |
|
每股賬面淨值
2.29
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
492.68M
|
|
每股收益
15.11
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 18:39 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio includes ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for several days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States. |